位置:首页 > 蛋白库 > CO5A2_MOUSE
CO5A2_MOUSE
ID   CO5A2_MOUSE             Reviewed;        1497 AA.
AC   Q3U962; Q3TVR2; Q3UHK7; Q3UTT4; Q3V1J6; Q61431; Q7TMS0; Q80VS8;
DT   03-APR-2007, integrated into UniProtKB/Swiss-Prot.
DT   11-OCT-2005, sequence version 1.
DT   03-AUG-2022, entry version 122.
DE   RecName: Full=Collagen alpha-2(V) chain;
DE   Flags: Precursor;
GN   Name=Col5a2 {ECO:0000312|MGI:MGI:88458};
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:AAA37440.1}
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND DEVELOPMENTAL STAGE.
RC   STRAIN=BALB/cJ {ECO:0000312|EMBL:AAA37440.1};
RX   PubMed=1297453; DOI=10.1002/aja.1001950205;
RA   Andrikopoulos K., Suzuki H.R., Solursh M., Ramirez F.;
RT   "Localization of pro-alpha 2(V) collagen transcripts in the tissues of the
RT   developing mouse embryo.";
RL   Dev. Dyn. 195:113-120(1992).
RN   [2] {ECO:0000312|EMBL:BAE30805.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J {ECO:0000312|EMBL:BAE30805.1};
RC   TISSUE=Bone marrow {ECO:0000312|EMBL:BAE30805.1},
RC   Cerebellum {ECO:0000312|EMBL:BAE23896.1},
RC   Embryo {ECO:0000312|EMBL:BAE27775.1},
RC   Placenta {ECO:0000312|EMBL:BAE27850.1}, and
RC   Skin {ECO:0000312|EMBL:BAE21154.1};
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3] {ECO:0000312|EMBL:AAH55077.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C3H/He {ECO:0000312|EMBL:AAH55077.1};
RC   TISSUE=Mammary gland {ECO:0000312|EMBL:AAH43696.1}, and
RC   Mesenchymal stem cell {ECO:0000312|EMBL:AAH55077.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4] {ECO:0000305}
RP   FUNCTION.
RX   PubMed=7704020; DOI=10.1038/ng0195-31;
RA   Andrikopoulos K., Liu X., Keene D.R., Jaenisch R., Ramirez F.;
RT   "Targeted mutation in the col5a2 gene reveals a regulatory role for type V
RT   collagen during matrix assembly.";
RL   Nat. Genet. 9:31-36(1995).
RN   [5] {ECO:0000305}
RP   FUNCTION.
RX   PubMed=9642685; DOI=10.1007/bf03401742;
RA   Phelps R.G., Murai C., Saito S., Hatakeyama A., Andrikopoulos K.,
RA   Kasturi K.N., Bona C.A.;
RT   "Effect of targeted mutation in collagen V alpha 2 gene on development of
RT   cutaneous hyperplasia in tight skin mice.";
RL   Mol. Med. 4:356-360(1998).
RN   [6] {ECO:0000305}
RP   SUBUNIT.
RX   PubMed=15199158; DOI=10.1128/mcb.24.13.6049-6057.2004;
RA   Chanut-Delalande H., Bonod-Bidaud C., Cogne S., Malbouyres M., Ramirez F.,
RA   Fichard A., Ruggiero F.;
RT   "Development of a functional skin matrix requires deposition of collagen V
RT   heterotrimers.";
RL   Mol. Cell. Biol. 24:6049-6057(2004).
CC   -!- FUNCTION: Type V collagen is a member of group I collagen (fibrillar
CC       forming collagen). It is a minor connective tissue component of nearly
CC       ubiquitous distribution. Type V collagen binds to DNA, heparan sulfate,
CC       thrombospondin, heparin, and insulin. Type V collagen is a key
CC       determinant in the assembly of tissue-specific matrices.
CC       {ECO:0000250|UniProtKB:P05997, ECO:0000269|PubMed:1297453,
CC       ECO:0000269|PubMed:7704020, ECO:0000269|PubMed:9642685}.
CC   -!- SUBUNIT: Trimers of two alpha 1(V) and one alpha 2(V) chains expressed
CC       in most tissues and trimers of one alpha 1(V), one alpha 2(V), and one
CC       alpha 3(V) chains with a more limited distribution of expression.
CC       {ECO:0000250|UniProtKB:P05997, ECO:0000269|PubMed:15199158}.
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
CC       matrix {ECO:0000255|PROSITE-ProRule:PRU00793}.
CC   -!- DEVELOPMENTAL STAGE: Expressed in embryos from 9 days of gestation
CC       onward. In 12.5 dpc embryos, low and diffuse level of expression was
CC       observed in the peritoneal membranes and intestinal and craniofacial
CC       mesenchymes. By 16.5 dpc, expression is higher and exhibits a more
CC       restricted accumulation in primary ossified regions, perichondrium,
CC       joints, tendon, atrioventricular valve of heart, and in selected
CC       portions of the head. {ECO:0000269|PubMed:1297453}.
CC   -!- DOMAIN: The C-terminal propeptide, also known as COLFI domain, have
CC       crucial roles in tissue growth and repair by controlling both the
CC       intracellular assembly of procollagen molecules and the extracellular
CC       assembly of collagen fibrils. It binds a calcium ion which is essential
CC       for its function (By similarity). {ECO:0000250}.
CC   -!- PTM: Prolines at the third position of the tripeptide repeating unit
CC       (G-X-P) are hydroxylated in some or all of the chains. Probably 3-
CC       hydroxylated on prolines by LEPREL1.
CC   -!- PTM: Hydroxylation on proline residues within the sequence motif, GXPG,
CC       is most likely to be 4-hydroxy as this fits the requirement for 4-
CC       hydroxylation in vertebrates. {ECO:0000250}.
CC   -!- MISCELLANEOUS: Mice homozygous for the targeted deletion of the N-
CC       terminal telopeptide segment of the COL5A2 chain show poor survival
CC       rates, possibly because of complications from spinal deformities, and
CC       exhibit skin and eye abnormalities caused by disorganized type I
CC       collagen fibrils. {ECO:0000269|PubMed:15199158,
CC       ECO:0000269|PubMed:7704020, ECO:0000269|PubMed:9642685}.
CC   -!- MISCELLANEOUS: The alpha 1(V)-alpha 1(V)-alpha 2(V) heterotrimer makes
CC       a critical contribution to fibrillogenesis, basement membrane
CC       organization, and cell viability, and may play a possible role in the
CC       development of a functional skin matrix. {ECO:0000269|PubMed:15199158}.
CC   -!- SIMILARITY: Belongs to the fibrillar collagen family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00793}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAE23896.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L02918; AAA37440.1; -; mRNA.
DR   EMBL; AK132413; BAE21154.1; -; mRNA.
DR   EMBL; AK139130; BAE23896.1; ALT_INIT; mRNA.
DR   EMBL; AK147220; BAE27775.1; -; mRNA.
DR   EMBL; AK147328; BAE27850.1; -; mRNA.
DR   EMBL; AK151929; BAE30805.1; -; mRNA.
DR   EMBL; AK160008; BAE35556.1; -; mRNA.
DR   EMBL; BC043696; AAH43696.1; -; mRNA.
DR   EMBL; BC055077; AAH55077.1; -; mRNA.
DR   CCDS; CCDS35555.1; -.
DR   PIR; I49607; I49607.
DR   RefSeq; NP_031763.2; NM_007737.2.
DR   AlphaFoldDB; Q3U962; -.
DR   SMR; Q3U962; -.
DR   BioGRID; 198822; 8.
DR   ComplexPortal; CPX-2962; Collagen type V trimer variant 1.
DR   ComplexPortal; CPX-2963; Collagen type V trimer variant 2.
DR   ComplexPortal; CPX-2976; Collagen type XI trimer variant 2.
DR   ComplexPortal; CPX-2977; Collagen type XI trimer variant 3.
DR   STRING; 10090.ENSMUSP00000083620; -.
DR   GlyGen; Q3U962; 2 sites.
DR   iPTMnet; Q3U962; -.
DR   PhosphoSitePlus; Q3U962; -.
DR   CPTAC; non-CPTAC-4024; -.
DR   MaxQB; Q3U962; -.
DR   PaxDb; Q3U962; -.
DR   PeptideAtlas; Q3U962; -.
DR   PRIDE; Q3U962; -.
DR   ProteomicsDB; 283544; -.
DR   Antibodypedia; 34019; 169 antibodies from 28 providers.
DR   DNASU; 12832; -.
DR   Ensembl; ENSMUST00000086430; ENSMUSP00000083620; ENSMUSG00000026042.
DR   GeneID; 12832; -.
DR   KEGG; mmu:12832; -.
DR   UCSC; uc007awr.1; mouse.
DR   CTD; 1290; -.
DR   MGI; MGI:88458; Col5a2.
DR   VEuPathDB; HostDB:ENSMUSG00000026042; -.
DR   eggNOG; KOG3544; Eukaryota.
DR   GeneTree; ENSGT00940000155675; -.
DR   HOGENOM; CLU_001074_2_3_1; -.
DR   InParanoid; Q3U962; -.
DR   OMA; MANWAEA; -.
DR   OrthoDB; 1406711at2759; -.
DR   PhylomeDB; Q3U962; -.
DR   TreeFam; TF344135; -.
DR   Reactome; R-MMU-1442490; Collagen degradation.
DR   Reactome; R-MMU-1474244; Extracellular matrix organization.
DR   Reactome; R-MMU-1650814; Collagen biosynthesis and modifying enzymes.
DR   Reactome; R-MMU-186797; Signaling by PDGF.
DR   Reactome; R-MMU-2022090; Assembly of collagen fibrils and other multimeric structures.
DR   Reactome; R-MMU-216083; Integrin cell surface interactions.
DR   Reactome; R-MMU-3000171; Non-integrin membrane-ECM interactions.
DR   Reactome; R-MMU-3000178; ECM proteoglycans.
DR   Reactome; R-MMU-419037; NCAM1 interactions.
DR   Reactome; R-MMU-8874081; MET activates PTK2 signaling.
DR   Reactome; R-MMU-8948216; Collagen chain trimerization.
DR   BioGRID-ORCS; 12832; 1 hit in 76 CRISPR screens.
DR   ChiTaRS; Col5a2; mouse.
DR   PRO; PR:Q3U962; -.
DR   Proteomes; UP000000589; Chromosome 1.
DR   RNAct; Q3U962; protein.
DR   Bgee; ENSMUSG00000026042; Expressed in vault of skull and 255 other tissues.
DR   Genevisible; Q3U962; MM.
DR   GO; GO:0005581; C:collagen trimer; IDA:MGI.
DR   GO; GO:0005588; C:collagen type V trimer; ISO:MGI.
DR   GO; GO:0005592; C:collagen type XI trimer; IC:ComplexPortal.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; HDA:UniProtKB.
DR   GO; GO:0031012; C:extracellular matrix; IBA:GO_Central.
DR   GO; GO:0005615; C:extracellular space; HDA:BHF-UCL.
DR   GO; GO:0005201; F:extracellular matrix structural constituent; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0046332; F:SMAD binding; IPI:MGI.
DR   GO; GO:0071230; P:cellular response to amino acid stimulus; IDA:MGI.
DR   GO; GO:0030199; P:collagen fibril organization; IMP:UniProtKB.
DR   GO; GO:0030198; P:extracellular matrix organization; IBA:GO_Central.
DR   GO; GO:0048592; P:eye morphogenesis; ISO:MGI.
DR   GO; GO:1903225; P:negative regulation of endodermal cell differentiation; ISO:MGI.
DR   GO; GO:0001503; P:ossification; IEA:Ensembl.
DR   GO; GO:0001501; P:skeletal system development; IMP:MGI.
DR   GO; GO:0043588; P:skin development; IMP:UniProtKB.
DR   InterPro; IPR008160; Collagen.
DR   InterPro; IPR000885; Fib_collagen_C.
DR   InterPro; IPR001007; VWF_dom.
DR   Pfam; PF01410; COLFI; 1.
DR   Pfam; PF01391; Collagen; 6.
DR   Pfam; PF00093; VWC; 1.
DR   SMART; SM00038; COLFI; 1.
DR   SMART; SM00214; VWC; 1.
DR   PROSITE; PS51461; NC1_FIB; 1.
DR   PROSITE; PS01208; VWFC_1; 1.
DR   PROSITE; PS50184; VWFC_2; 1.
PE   1: Evidence at protein level;
KW   Calcium; Collagen; Disulfide bond; Extracellular matrix; Glycoprotein;
KW   Hydroxylation; Metal-binding; Reference proteome; Repeat; Secreted; Signal.
FT   SIGNAL          1..26
FT                   /evidence="ECO:0000255"
FT   CHAIN           27..1227
FT                   /note="Collagen alpha-2(V) chain"
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_0000283768"
FT   PROPEP          1228..1497
FT                   /note="C-terminal propeptide"
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_0000283769"
FT   DOMAIN          38..96
FT                   /note="VWFC"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00220"
FT   DOMAIN          1264..1497
FT                   /note="Fibrillar collagen NC1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00793"
FT   REGION          103..1265
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           141..143
FT                   /note="Cell attachment site"
FT                   /evidence="ECO:0000255"
FT   MOTIF           504..506
FT                   /note="Cell attachment site"
FT                   /evidence="ECO:0000255"
FT   MOTIF           942..944
FT                   /note="Cell attachment site"
FT                   /evidence="ECO:0000255"
FT   MOTIF           1065..1067
FT                   /note="Cell attachment site"
FT                   /evidence="ECO:0000255"
FT   MOTIF           1068..1070
FT                   /note="Cell attachment site"
FT                   /evidence="ECO:0000255"
FT   MOTIF           1125..1127
FT                   /note="Cell attachment site"
FT                   /evidence="ECO:0000255"
FT   MOTIF           1134..1136
FT                   /note="Cell attachment site"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        166..181
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        919..933
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1028..1042
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1127..1141
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1169..1183
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1210..1225
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         1312
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250"
FT   BINDING         1314
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250"
FT   BINDING         1315
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250"
FT   BINDING         1320
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         288
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         291
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         294
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         609
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         615
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        1260
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1398
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        1294..1326
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00793"
FT   DISULFID        1334..1495
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00793"
FT   DISULFID        1403..1448
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00793"
FT   CONFLICT        20
FT                   /note="Y -> D (in Ref. 2; BAE23896)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        88
FT                   /note="T -> P (in Ref. 1; AAA37440)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        160
FT                   /note="G -> R (in Ref. 2; BAE27850)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        164
FT                   /note="V -> M (in Ref. 1; AAA37440)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        222
FT                   /note="Q -> V (in Ref. 1; AAA37440)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        231
FT                   /note="V -> A (in Ref. 1; AAA37440)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        387
FT                   /note="A -> R (in Ref. 1; AAA37440)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        390
FT                   /note="T -> H (in Ref. 1; AAA37440)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        428
FT                   /note="A -> R (in Ref. 1; AAA37440)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        431
FT                   /note="P -> A (in Ref. 1; AAA37440)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        614
FT                   /note="L -> V (in Ref. 1; AAA37440 and 3; AAH55077)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        666
FT                   /note="Q -> A (in Ref. 1; AAA37440)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        809..813
FT                   /note="PTGEK -> LLGAP (in Ref. 1; AAA37440)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        851
FT                   /note="P -> S (in Ref. 1; AAA37440)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1001..1002
FT                   /note="ER -> VT (in Ref. 1; AAA37440)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1013
FT                   /note="T -> A (in Ref. 3; AAH55077)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1063
FT                   /note="G -> V (in Ref. 2; BAE21154)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1181
FT                   /note="P -> S (in Ref. 1; AAA37440)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1337
FT                   /note="A -> T (in Ref. 3; AAH55077)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1388
FT                   /note="L -> F (in Ref. 1; AAA37440)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1497 AA;  145018 MW;  CAAE15514984DB41 CRC64;
     MMANWVGARP LLILSVLLGY CVSIKAQEQE NDEYDEEIAC TQHGQMYLNR DIWKPSPCQI
     CVCDNGAILC DKIECPEVLN CANPITPTGE CCPVCPQTGG GDTSFGRGRK GQKGEPGLVP
     VVTGIRGRPG PAGPPGSQGP RGDRGPKGRP GPRGPQGIDG EPGVPGQPGA PGPPGHPSHP
     GPDGMSRPFS AQMAGLDEKS GLGSQVGLMP GSVGPVGPRG PQGLQGQQGG VGPAGPPGEP
     GEPGPMGPIG SRGPEGPPGK PGEDGEPGRN GNTGEVGFSG SPGARGFPGA PGLPGLKGHR
     GHKGLEGPKG EIGAPGAKGE AGPTGPMGAM GPLGPRGMPG ERGRLGPQGA PGKRGAHGMP
     GKPGPMGPLG IPGSSGFPGN PGMKGEAGPT GARGPEGPQG QRGETGPPGP AGSQGLPGAV
     GTDGTPGAKG PTGSAGTSGP PGLAGPPGSP GPQGSTGPQG IRGQSGDPGV PGFKGEAGPK
     GEPGPHGIQG PIGPPGEEGK RGPRGDPGTV GPPGPMGERG APGNRGFPGS DGLPGPKGAQ
     GERGPVGSSG PKGGQGDPGR PGEPGLPGAR GLTGNPGVQG PEGKLGPLGA PGEDGRPGPP
     GSIGIRGQPG SMGLPGPKGS SGDLGKPGEA GNAGVPGQRG APGKDGEVGP SGPVGPPGLA
     GERGEQGPPG PTGFQGLPGP PGPPGEGGKA GDQGVPGEPG AVGPLGPRGE RGNPGERGEP
     GITGLPGEKG MAGGHGPDGP KGNPGPTGTI GDTGPPGLQG MPGERGIAGT PGPKGDRGGI
     GEKGAEGTAG NDGARGLPGP LGPPGPAGPT GEKGEPGPRG LVGPPGSRGN PGSRGENGPT
     GAVGFAGPQG PDGQPGVKGE PGEPGQKGDA GSPGPQGLAG SPGPHGPHGV PGLKGGRGTQ
     GPPGATGFPG SAGRVGPPGP AGAPGPAGPA GEPGKEGPPG LRGDPGSHGR VGDRGPAGPP
     GSPGDKGDPG EDGQPGPDGP PGPAGTTGQR GIVGMPGQRG ERGMPGLPGP AGTPGKVGPT
     GATGDKGPPG PVGPPGSNGP VGEPGPEGPA GNDGTPGRDG AVGERGDRGD PGPAGLPGSQ
     GAPGTPGPVG APGDAGQRGE PGSRGPVGPP GRAGKRGLPG PQGPRGDKGD NGDRGDRGQK
     GHRGFTGLQG LPGPPGPNGE QGSAGIPGPF GPRGPPGPVG PSGKEGNPGP LGPIGPPGVR
     GSVGEAGPEG PPGEPGPPGP PGPPGHLTAA LGDIMGHYDE NMPDPLPEFT EDQAAPDDTN
     KTDPGIHVTL KSLSSQIETM RSPDGSKKHP ARTCDDLKLC HPTKQSGEYW IDPNQGSAED
     AIKVYCNMET GETCISANPA SVPRKTWWAS KSPDNKPVWY GLDMNRGSQF TYGDYQSPNT
     AITQMTFLRL LSKEASQNLT YICRNTVGYM DDQAKNLKKA VVLKGSNDLE IKGEGNIRFR
     YTVLQDTCSK RNGNVGKTIF EYRTQNVARL PIIDVGPVDI GNADQEFGLD IGPVCFM
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024